Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04093388 · ClinicalTrials.gov registry record · NA
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
A NA study of Cervical Cancer, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 3
- Study locations
NCT04093388 is a NA study of Cervical Cancer that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 250 participants, below the 569-participant average among 144 other Cervical Cancer trials with a reported enrollment target (56% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT04093388, a NA study of Cervical Cancer, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of the study is to find out if a self-administered (by the patient) Papanicolaou (Pap) smear is as accurate as a traditional Pap smear administered by a healthcare provider.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Self-PAP
- DIAGNOSTIC_TEST Traditional Pap smear
Study Locations (3)
Alabama
- Cahaba Medical Care - West End - Birmingham
- Cahaba Medical Care - Ensley - Birmingham
- Cahaba Medical Care - Centreville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-04-26 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04093388
The ClinicalTrials.gov registry entry for NCT04093388 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 569-participant average among 144 other Cervical Cancer trials with a reported enrollment target (56% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 2 interventions - of which Self-PAP is the first listed.
NCT04093388 reports 3 study locations spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT04093388 about?
NCT04093388 is a clinical study titled "Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama". The purpose of the study is to find out if a self-administered (by the patient) Papanicolaou (Pap) smear is as accurate as a traditional Pap smear administered by a healthcare provider.
What is the current status of trial NCT04093388?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2021-04-26. Estimated completion is 2026-06-30.
What conditions does trial NCT04093388 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT04093388?
The interventions under investigation include: Self-PAP (DIAGNOSTIC_TEST), Traditional Pap smear (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04093388?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04093388 being conducted?
This trial has 3 study locations across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.